Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Nov 03 2020

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 3 pages · English

Release

Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 03, 2020, titled "Zydus announces IND filing of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases